Data generated from our studies clearly demonstrated that Spry1KO led to the down-regulation of several MMPs, including MMP-2, MMP-3 and MMP-8, which have been recently explored as targets to hamper cancer angiogenesis and, in turn, tumor cell dissemination [45, 67–70]. Here, MMP2 is linked to cancer.